Search results for: alendronate

FDA Issues Safety Alerts for Bisphosphonates & SGLT2 Inhibitors

Michele B. Kaufman, PharmD, BCGP | May 20, 2015

Safety The Food and Drug Administration (FDA) has updated the Warnings and Precautions sections of prescribing information for the bisphosphonate agents, including risedronate sodium tablets and combinations with calcium (Actonel/Atelvia), alendronate and combinations with vitamin D (Binosto/Fosamax), ibandronate (Boniva), etidronate (Didronel) and the RANK-ligand inhibitor denosumab (Prolia/Xgeva).1 This information relates to an increased risk for…

Are Insurance Companies’ Medication Directives Fiscally, Medically Questionable?

Bruce Rothschild, MD | November 1, 2014

A reader questions whether insurers’ practice of promoting medications has undermined physicians’ ability to provide quality patient care

Atypical Fractures Associated with Bisphosphonates

Michele B. Kaufman, PharmD, BCGP | November 1, 2014

Plus, FX006, odanacatib and other rheumatology drug news, safety updates

New Treatments Needed to Prevent Fractures in Osteoporosis

Ellen M. Field, MD, FACR, CCD | June 1, 2014

Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | April 2, 2014

Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know

Rheuminations: New Rules for Rheumatologists

Simon M. Helfgott, MD | April 1, 2013

Transparent hospital costs, salary caps for senior hospital executives, and no more faxes top one rheumatologist’s wish list for revised healthcare rules

ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis

Thomas R. Collins | January 1, 2013

Rheumatology experts urge caution in using bisphosphonates to prevent bone loss

Drug Updates: Lorcaserin, Acetaminophen, and More

Michele B. Kaufman, PharmD, BCGP | September 5, 2012

information on new approvals and medication safety

Drug Updates: Citalopram hydrobromide, Statins, and More

Michele B. Kaufman, PharmD, BCGP | May 8, 2012

Information on new approvals and medication safety

Unexpected Benefits of Bisphosphonates after Hip Fracture

Cathleen Colon-Emeric, MD, MHS | February 3, 2012

Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.